Nyxoah SA Basic EPS 2021-2025 | NYXH
Nyxoah SA basic eps from 2021 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Nyxoah SA Annual Basic EPS | |
|---|---|
| 2024 | $-1.96 |
| 2023 | $-1.67 |
| 2022 | $-1.27 |
| 2021 | $-1.37 |
| 2020 | $-0.77 |
| Nyxoah SA Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $-0.63 |
| 2024-12-31 | $-0.50 |
| 2024-09-30 | $-0.55 |
| 2024-06-30 | $-0.46 |
| 2024-03-31 | $-0.45 |
| 2023-12-31 | $-0.40 |
| 2023-09-30 | $-0.29 |
| 2023-06-30 | $-0.49 |
| 2023-03-31 | $-0.49 |
| 2022-12-31 | $-0.53 |
| 2022-09-30 | $-0.24 |
| 2022-06-30 | $-0.21 |
| 2022-03-31 | $-0.29 |
| 2021-12-31 | |
| 2021-06-30 | |
| 2021-03-31 | $-0.31 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.264B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.064B | 58.60 |
| Hims & Hers Health (HIMS) | United States | $13.260B | 137.77 |
| Tempus AI (TEM) | United States | $12.137B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.628B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.753B | 58.64 |
| Hinge Health (HNGE) | United States | $2.965B | 0.00 |
| Privia Health (PRVA) | United States | $2.730B | 186.58 |
| Enovis (ENOV) | United States | $1.764B | 9.83 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Phreesia (PHR) | United States | $1.519B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.440B | 0.00 |
| Azenta (AZTA) | United States | $1.342B | 62.36 |
| Omnicell (OMCL) | United States | $1.335B | 23.55 |
| 10x Genomics (TXG) | United States | $1.300B | 0.00 |
| Claritev (CTEV) | United States | $0.661B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.617B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.544B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 142.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.387B | 0.00 |
| TruBridge (TBRG) | United States | $0.348B | 771.33 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| American Well (AMWL) | United States | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.099B | 3.79 |
| MDxHealth SA (MDXH) | Belgium | $0.093B | 0.00 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.043B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |